Tags |
|
|
Links |
|
|
Top Articles - Financial Leverage And Return On Equity-What is Leverage?
You've probably heard the term before, leverage, but what exactly does it mean? Another term is gearing. So when
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
you use this, you are also doing what can be called gearing. In essence means using the resources that are availa
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
le to magnify the positive or negative aspect in the final product or result.
Usually when you do this type of d
Usually when you do this type of d
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
aling in business or finance, it is similar or synonymous with borrowing. This greatly involves ROA (return on as
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ets) and ROE (return on equity). The main point is to make ROE higher than the ROA. If it is not, leverage or bor
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
owing can be used.
Some of the basics of how this leverage works include reinvesting a previous loan. When you r
Some of the basics of how this leverage works include reinvesting a previous loan. When you r
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
invest the loan you are borrowing or using leverage to get a better ROE on your loan. This type of leverage can i
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
nvolve a lot of risk, but to many it is very much worth it. This is because leverage can give you better returns
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
nd greater potential as well.
There is also a theory called the Modigliani-Miller theorem that involves leverage
There is also a theory called the Modigliani-Miller theorem that involves leverage
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
This theory has to do with a company's equity versus their debt. For example, one that has none actually is know
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
as an all equity firm. While one that has leverage is one that has both equity and debt. The value of the ratio
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
etween the two is how much leverage the company has available to them.
There is yet another form of leverage tha
There is yet another form of leverage tha
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
involves the use of options. Usually something called a call option is purchased. This gives the investor an adv
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ntage because they are able to purchase these options at what is called the underlying security at any time. The
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
value of the actual security will rise more sharply then the underlying one. This gives the investor a lot of abi
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ity to earn more money if value increases. There is of course a risk in this as well, but the leverage that can b
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
gained from it is invaluable.
In general when you use leverage, you will be taking some risks. In the end, a lo
In general when you use leverage, you will be taking some risks. In the end, a lo
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
of people will find that the benefits of using this technique far outweigh these risks. This is because a lot ca
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
be gained if leverage is used in the right time and in the right place. Make sure you carefully weigh the pros a
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
d cons before you decide to use leverage for yourself. But if you should decide to do so, you may be glad you did
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.toparticles.org.ua/article/102260/toparticles-Financial-Leverage-And-Return-On-EquityWhat-is-Leverage.html">Financial Leverage And Return On Equity-What is Leverage?</a>
BB link (for phorums):
[url=http://www.toparticles.org.ua/article/102260/toparticles-Financial-Leverage-And-Return-On-EquityWhat-is-Leverage.html]Financial Leverage And Return On Equity-What is Leverage?[/url]
Related Articles:
Is Your Marketing Kitchen Really Cookin'?
Management Features of Sales Force Automation
eBay’s Site Map Can Put Money In Your Pocket
Bookmark it:
|